Hat mitgewirkt an:
-
“Will I change nodule management recommendations if I change my CAD system?”—impact of volumetric deviation between different CAD systems on lesion management
-
Imaging Biomarkers in Thoracic Oncology: Current Advances in the Use of Radiomics in Lung Cancer Patients and its Potential Use for Therapy Response Prediction and Monitoring
-
Reproducibility and comparison of oxygen-enhanced T_1 quantification in COPD and asthma patients
-
Quantitative CT analysis of lung parenchyma to improve malignancy risk estimation in incidental pulmonary nodules